Tevogen Bio(TVGN) - 2024 Q1 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2024 Tevogen Bio Holdings Inc. (Exact name of registrant as specified in its charter) Delaware 001-41002 85-1284695 (State or other jurisdiction of incorporation) 15 Independence Boulevard, Suite #410 Warren, New Jersey 07059 (Address of principal executive offices) (Zip Code) Registr ...